Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial.

Shrank WH, Choudhry NK, Solomon DH, Snedden TM, Lee TH, Glynn RJ, Brown TV, Jolda C, Spetman M, Brookhart MA, Schneeweiss S, Avorn J.

Am Heart J. 2009 Apr;157(4):613-9. doi: 10.1016/j.ahj.2008.12.006.

2.

Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.

Li P, McElligott S, Bergquist H, Schwartz JS, Doshi JA.

Ann Intern Med. 2012 Jun 5;156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. doi: 10.7326/0003-4819-156-11-201206050-00004.

PMID:
22665815
3.
4.
5.
6.
7.

Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study.

Heinze G, Hronsky M, Reichardt B, Baumgärtel C, Müllner M, Bucsics A, Winkelmayer WC.

Appl Health Econ Health Policy. 2015 Apr;13(2):193-205. doi: 10.1007/s40258-014-0143-4.

PMID:
25536928
8.
10.

[Health care too costly? Saving more than 10 million euros in 2 months!].

Rappert B.

MMW Fortschr Med. 2003 Nov 20;145(47):65. German. No abstract available.

PMID:
14725043
11.

Prevalence and predictors of utilization of community pharmacy generic drug discount programs.

Gatwood J, Tungol A, Truong C, Kucukarslan SN, Erickson SR.

J Manag Care Pharm. 2011 Jul-Aug;17(6):449-55.

12.
14.
15.

Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?

Ara R, Pandor A, Stevens J, Rafia R, Ward SE, Rees A, Durrington PN, Reynolds TM, Wierzbicki AS, Stevenson M.

Eur J Prev Cardiol. 2012 Jun;19(3):474-83. doi: 10.1177/1741826711406616.

PMID:
21460076
16.

The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*.

Chapman RH, Ferrufino CP, Kowal SL, Classi P, Roberts CS.

Int J Clin Pract. 2010 Jan;64(2):169-81. doi: 10.1111/j.1742-1241.2009.02196.x. Review.

PMID:
20089007
17.

Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use.

Shrank WH, Stedman M, Ettner SL, DeLapp D, Dirstine J, Brookhart MA, Fischer MA, Avorn J, Asch SM.

J Gen Intern Med. 2007 Sep;22(9):1298-304.

18.

Quality circles to improve prescribing of primary care physicians. Three comparative studies.

Wensing M, Broge B, Riens B, Kaufmann-Kolle P, Akkermans R, Grol R, Szecsenyi J.

Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):763-9. doi: 10.1002/pds.1778.

PMID:
19507170
20.

Evidence Brief: The Quality of Care Provided by Advanced Practice Nurses.

McCleery E, Christensen V, Peterson K, Humphrey L, Helfand M.

VA Evidence-based Synthesis Program Evidence Briefs [Internet]. Washington (DC): Department of Veterans Affairs (US); 2011-.
2014 Sep.

Items per page

Supplemental Content

Support Center